Details for 2013721243

Up to date per 01.04.2026

Actions

Title / Product Name

ANTI-CD38-ANTIKÖRPER UND FUSIONEN DAVON MIT ABGESCHWÄCHTEM INTERFERON-ALPHA-2B

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013721243

EP Publication Number

2992013

E-Number

1209296

Language

PCT Number

US13038659

Publication Date

09.03.2016 A

04.12.2019 B1

Registration Date

04.12.2019

AT Publication Date

15.12.2019

Application Date

29.04.2013

Registration Number

Priorities

IPC

C07K 16/28 20060101AFI20141113BHEP

Maximum Duration of Protection

29.04.2033

Owner

Teva Pharmaceuticals Australia Pty LtdLevel 2 37 Epping Road Macquarie Park, NSW 2113AU

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

CLARKE, Adam37 Epping Road Level 2 Macquarie Park, NSW 2113AU

POLLARD, Matthew37 Epping Road Level 2 Macquarie Park, NSW 2113AU

DOYLE, Anthony, Gerard37 Epping Road Level 2 Macquarie Park, NSW 2113AT

BEHRENS, Collette37 Epping Road Level 2 Macquarie Park, NSW 2113AU

YAMAGISHI, Tetsuo37 Epping Road Level 2 Macquarie Park, NSW 2113AU

WILSON, David, S. Jr.610 Galveston Drive Redwood City, CA 94063US

POGUE, Sarah, L.5471 Midday Common Freemont, CA 94555US

TAURA, Tetsuya514 Driscoll Place Palo Alto, CA 94306US

Information about Fees